Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Anatomic distribution of Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium infections in men who have sex with men

N. Reinton A , H. Moi B , A. O. Olsen B , N. Zarabyan A , J. Bjerner A , T. M. Tønseth C and A. Moghaddam A D

A Fürst Medisinsk Laboratorium, Søren Bulls vei 25, N-1051 Oslo, Norway.

B Department of Rheumatology, Dermatology and Infectious Diseases, The Olafia Clinic, Oslo University Hospital, and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0560 Oslo, Norway.

C Brynsenglegene, Brynsengveien 2, 0667 Oslo, Norway.

D Corresponding author. Email: amoghaddam@furst.no

Sexual Health 10(3) 199-198 https://doi.org/10.1071/SH12092
Submitted: 22 June 2012  Accepted: 3 December 2012   Published: 5 April 2013

Abstract

Background: New cases of gonorrhoea (Neisseria gonorrhoeae) and chlamydia (Chlamydia trachomatis) infections have been steadily increasing in Scandinavian countries over the last decade. There is a particular urgency in reducing new infections as isolation of multiple drug resistant strains of gonorrhoea is becoming more frequent. The aim of this study was to determine the prevalence and sites of infection of common sexually transmissible infections (STIs) in men who have sex with men (MSM). Methods: We have performed a retrospective analysis of the three major STIs, gonorrhoea, chlamydia and Mycoplasma genitalium in urogenital, anorectal and oropharyngeal samples from MSM that attended two STI clinics in Oslo. Results: One hundred and thirty-six men (6.0%) out of 2289 MSM tested were found to be positive for gonorrhoea using a porA gene targeted nucleic acid amplification test (NAAT). Of these, 106 (77.9%) would not have been identified through testing first-void urine alone. Two hundred and twenty eight (10.0%) patients from 2289 tested were found to be positive for chlamydia, 164 (71.9%) of which were identified through anorectal specimens. Ninety-one (5.1%) patients from 1778 tested were found to be positive for M. genitalium, with 65 (71.4%) identified through testing of anorectal specimens. Conclusions: Our results supports the European findings that the MSM population carries a high burden of STIs and that testing the anorectum and oropharynx will identify a significantly higher percentage of infected patients and reservoirs of STIs.

Additional keywords: anorectal samples, Norway, oropharyngeal samples, Scandinavia, urogenital samples.


References

[1]  Moi H. Care of sexually transmitted infections in the Nordic countries. Int J STD AIDS 2001; 12 819–23.
Care of sexually transmitted infections in the Nordic countries.CrossRef | 1:STN:280:DC%2BD38%2Flt1KhtQ%3D%3D&md5=382dda344dc1738e7695cdf7d354ead8CAS | 11779374PubMed | open url image1

[2]  Noar SM. Behavioral interventions to reduce HIV-related sexual risk behavior: review and synthesis of meta-analytic evidence. AIDS Behav 2008; 12 335–53.
Behavioral interventions to reduce HIV-related sexual risk behavior: review and synthesis of meta-analytic evidence.CrossRef | 17896176PubMed | open url image1

[3]  Fenton KA, Imrie J. Increasing rates of sexually transmitted diseases in homosexual men in Western europe and the United States: why? Infect Dis Clin North Am 2005; 19 311–31.
Increasing rates of sexually transmitted diseases in homosexual men in Western europe and the United States: why?CrossRef | 15963874PubMed | open url image1

[4]  Nasjonalt Folkehelseinstituttet. Gonoré og syfilis i Norge 2011. Oslo: Nasjonalt Folkehelseinstituttet; 2012. Available online at: http://www.fhi.no/eway/default.aspx?pid=233&trg=Area_5774&MainArea_5661=5588:0:15,1787:1:0:0:0:0&MainLeft_5588=5774:0:15,1787:1:0:0:0:0&Area_5774=5544:97000:1:5776:1:0:0 [verified January 2013]

[5]  Health Protection Agency (HPA) GRASP: the Gonococcal Resistance to Antimicrobials Surveillance Programme. London: HPA; 2009. Available online at: http://www.hpa.org.uk/web/HPAweb&Page&HPAwebAutoListName/Page/1221117908959 [verified January 2013].

[6]  Chisholm SA, Alexander S, Desouza-Thomas L, Maclure-Webster E, Anderson J, Nichols T, et al Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales. J Antimicrob Chemother 2011; 66 2509–12.
Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.CrossRef | 1:CAS:528:DC%2BC3MXhtlaqtbfO&md5=a42b6843ba272e2aad254abe836f883bCAS | 21846672PubMed | open url image1

[7]  Cole MJ, Unemo M, Hoffmann S, Chisholm S, Ison C, van de Laar MJ. The European gonococcal antimicrobial surveillance programme, 2009. Eurosurveillance. 2011; 16 1–6. open url image1

[8]  World Health Organisation (WHO) The WHO Western Pacific Gonococcal Antimicrobial Surveillance Program. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2001. World Health Organization. Commun Dis Intell 2002; 26 541–5. open url image1

[9]  Nasjonalt Folkehelseinstituttet. Klamydiainfeksjoner i Norge 2010. Oslo: Nasjonalt Folkehelseinstitutte; 2011. Available online at: http://www.fhi.no/eway/default.aspx?pid=233&trg=Area_5774&MainArea_5661=5588:0:15,1787:1:0:0:0:0&MainLeft_5588=5774:0:15,1787:1:0:0:0:0&Area_5774=5544:89844:1:5776:1:0:0 [verified January 2013]

[10]  Savage EJ, van de Laar MJ, Gallay A, van der Sande M, Hamouda O, Sasse A, et al Lymphogranuloma venereum in Europe, 2003–2008. Eurosurveillance. 2009; 14
| 1:CAS:528:DC%2BD1MXmt1Snsbo%3D&md5=08893222850f8c2e707952292a5ef3c1CAS | 20003898PubMed | open url image1

[11]  de Vries H, Morré S, White J, Moi H. European guideline for the management of lymphogranuloma venereum, 2010. Int J STD AIDS 2010; 21 533–6.
European guideline for the management of lymphogranuloma venereum, 2010.CrossRef | 1:STN:280:DC%2BC3cbitFartA%3D%3D&md5=dd48cbc0627eb6bdf68c6712f3b200f6CAS | 20975083PubMed | open url image1

[12]  Ross JDC, Jensen JS. Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment. Sex Transm Infect 2006; 82 269–71.
Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment.CrossRef | 1:STN:280:DC%2BD28vlsVarug%3D%3D&md5=b7d2a36d08e273881e6169bb9f6b9da1CAS | open url image1

[13]  Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008; 47 1546–53.
Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance.CrossRef | 1:CAS:528:DC%2BD1MXjs1Ohsw%3D%3D&md5=03a4ebe35ebdc6912e46046006e75d12CAS | 18990060PubMed | open url image1

[14]  Jernberg E, Moghaddam A, Moi H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 2008; 19 676–9.
Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study.CrossRef | 1:STN:280:DC%2BD1cnjtlGrtg%3D%3D&md5=b7b601bcfec1e62d0f457559b63f9be1CAS | 18824619PubMed | open url image1

[15]  Blystad H, Klouman E. Recommendation for annual HIV and STI testing in MSM introduced in Norway. Eurosurveillance 2005; 10
| 16794276PubMed | open url image1

[16]  Hjelmevoll SO, Olsen ME, Sollid JUE, Haaheim H, Melby KK, Moi H, et al Clinical validation of a real-time polymerase chain reaction detection of Neisseria gonorrheae porA pseudogene versus culture techniques. Sex Transm Dis 2008; 35 517–20.
Clinical validation of a real-time polymerase chain reaction detection of Neisseria gonorrheae porA pseudogene versus culture techniques.CrossRef | 1:CAS:528:DC%2BD1cXlt1agt7k%3D&md5=df07d4107a362807013cc2f193c50efcCAS | 18434945PubMed | open url image1

[17]  Moi H, Reinton N. Moghaddam A. Mycoplasma genitalium is associated with symptomatic and asymptomatic non-gonococcal urethritis in men. Sex Transm Infect 2009; 85 15–8.
Moghaddam A. Mycoplasma genitalium is associated with symptomatic and asymptomatic non-gonococcal urethritis in men.CrossRef | 1:STN:280:DC%2BD1M%2Fos12hsw%3D%3D&md5=58fe5a2b4fc91d522e5046982c7e44f0CAS | 18842690PubMed | open url image1

[18]  Chen C-Y, Chi K-H, Alexander S, Martin IMC, Liu H, Ison CA, et al The molecular diagnosis of lymphogranuloma venereum: evaluation of a real-time multiplex polymerase chain reaction test using rectal and urethral specimens. Sex Transm Dis 2007; 34 451–5.
| 17075436PubMed | open url image1

[19]  Hopkins MJ, Ashton LJ, Alloba F, Alawattegama A, Hart IJ. Validation of a laboratory-developed real-time PCR protocol for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine. Sex Transm Infect 2010; 86 207–11.
Validation of a laboratory-developed real-time PCR protocol for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine.CrossRef | 1:STN:280:DC%2BC3czps1Chsg%3D%3D&md5=60b14d2ff2ad37fcdaee291579b11294CAS | 20522633PubMed | open url image1

[20]  Moghaddam A, Reinton N. Identification of the Swedish Chlamydia trachomatis variant among patients attending a STI clinic in Oslo, Norway. Eurosurveillance 2007; 12 E070301.3
| 1:STN:280:DC%2BD2s3jtFChug%3D%3D&md5=69e291fe179b05296359ea172c3fbc15CAS | 17439779PubMed | open url image1

[21]  Nasjonalt Folkehelseinstituttet. Gonoré og syfilis i Norge 2010. Oslo: Nasjonalt Folkehelseinstituttet; 2011. Available online at: http://www.fhi.no/eway/default.aspx?pid=233&trg=MainLeft_5588&MainArea_5661=5588:0:15,1787:1:0:0:0:0&MainLeft_5588=5544:89770:1:5569:1:0:0 [verified January 2013]

[22]  Smittskyddsinstitutet. Statistik över smittsamma sjukdomar. Strömsund: Smittskyddsinstitutet; Available online at: www.smittskyddsinstitutet.se/statistik [verified January 2013]

[23]  Schachter J, Philip SS. Testing men who have sex with men for urethral infection with Chlamydia trachomatis and Neisseria gonorrhoeae is only half the job, and we need the right tools. Sex Transm Dis 2011; 38 925–7.
Testing men who have sex with men for urethral infection with Chlamydia trachomatis and Neisseria gonorrhoeae is only half the job, and we need the right tools.CrossRef | 21934566PubMed | open url image1

[24]  Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008; 35 637–42.
Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men.CrossRef | 1:CAS:528:DC%2BD1cXnslagu70%3D&md5=6c21de8df053fd8ded88d623cd11a719CAS | 18520976PubMed | open url image1

[25]  Bernstein KT, Stephens SC, Barry PM, Kohn R, Philip SS, Liska S, et al Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the oropharynx to the urethra among men who have sex with men. Clinical infectious diseases 2009; 49 1793–7.
Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the oropharynx to the urethra among men who have sex with men.CrossRef | 19911970PubMed | open url image1

[26]  Marcus JL, Kohn RP, Barry PM, Philip SS, Bernstein KT. Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the female oropharynx to the male urethra. Sex Transm Dis 2011; 38 372–3.
Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the female oropharynx to the male urethra.CrossRef | 21183864PubMed | open url image1

[27]  Ameyama S, Onodera S, Takahata M, Minami S, Maki N, Endo K, et al Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob Agents Chemother 2002; 46 3744–9.
Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime.CrossRef | 1:CAS:528:DC%2BD38XptVyntrk%3D&md5=e3189492d93458dc122eba360e0feab2CAS | 12435671PubMed | open url image1

[28]  Jensen AJ, Kleveland CR, Moghaddam A, Haaheim H, Hjelmevoll SO, Skogen V. Chlamydia trachomatis, Mycoplasma genitalium, and Ureaplasma urealyticum among students in northern Norway. J Eur Acad Dermatol Venereol 2012; in press.
| 22449180PubMed | open url image1

[29]  Peters RPH, Verweij SP, Nijsten N, Ouburg S, Mutsaers J, Jansen CL, et al Evaluation of sexual history-based screening of anatomic sites for Chlamydia trachomatis and Neisseria gonorrhoeae infection in men having sex with men in routine practice. BMC Infect Dis 2011; 11 203–9.
Evaluation of sexual history-based screening of anatomic sites for Chlamydia trachomatis and Neisseria gonorrhoeae infection in men having sex with men in routine practice.CrossRef | open url image1

[30]  Hartgill U, Jakopanec I, Vestrheim DF. Gonorrhea –time for new guidelines. [In Norwegian] Tidsskr Nor Laegeforen 2011; 131(7): 671–2.

[31]  Mayaud P, McCormick D. Interventions against sexually transmitted infections (STI) to prevent HIV infection. Br Med Bull 2001; 58 129–53.
Interventions against sexually transmitted infections (STI) to prevent HIV infection.CrossRef | 1:STN:280:DC%2BD3MnmvFamug%3D%3D&md5=f6f148780a20027cfb2ec3ec799bf580CAS | 11714628PubMed | open url image1



Rent Article (via Deepdyve) Export Citation Cited By (2)